Survey: Uncertainty is widespread and skepticism high around return to work and COVID vaccine

Fresh research reveals that nearly 20% of U.S. workers are unsure about taking vaccine, and that there’s a troubling gender gap on return-to-workplace plans.

Ragan Insider Premium Content
COVID vaccine skepticism

We’re seeing real progress in the fight against COVID-19.

Numbers are “plummeting” in many parts of the country, and there is growing hope that widespread vaccinations could, finally, help bring this horrific pandemic to an end. Unfortunately, skepticism about the efficacy of the COVID-19 vaccine remains surprisingly high.

New research from The Conference Board finds that one in five employees have reservations about whether or not they’ll get the shot. The survey also revealed a stark divide of opinion between senior- and junior-level employees. Other findings include:   

  • Lower-ranking employees are far more uncertain about taking the vaccine than senior leaders.
  • 45% of companies have not communicated a vaccination policy.
  • 44% say plans to reopen the workplace are unknown.
  • 28% of respondents say it will take seven to 12 months for their workplace to reopen.
  • Men report comfort in returning to the workplace at two times the rate of women.
To read the full story, log in.
Become a Ragan Insider member to read this article and all other archived content.
Sign up today

Already a member? Log in here.
Learn more about Ragan Insider.